| |
 |
| Online: |
| ¬ User: 0 |
| ¬ Gäste: 72 |
| Besucher: |
| ¬ Heute: 893 |
| ¬ Gestern: 995 |
| ¬ Gesamt: 2015162 |
| ¬ ø Tag: 242.88 |
| Max.: |
| ¬ pro Tag: 3598 |
| ¬ Online: 540 |
| |
|
 |
|
|
|
| Forum |
| » Hauptforum » Forum: Allgemein » Thread: Renub Research | Global biopsy device ma |
| |
| [ Neuer Eintrag - letzter Post ] |
| Thread |
 Seite: « 1 » |
| #1 |
» 05.07.19 11:42h |
|
|
The surgically removal of a tissue from any human organ to know the presence of a disease especially cancer is called biopsy. This medical procedure is done by surgeons, cardiologist and radiologist. Global  Biopsy Device Market is anticipated to surpass USD 2.8 Billion by the year end of 2025. The main factor that fuel the market growth is minimal invasive surgical procedure which mitigate the complications and side-effects and proliferating the biopsy device. Increasing private funding for cancer research, government expenditure on healthcare across the world, rising technological up-gradation and favorable reimbursement policies will further propel the global biopsy device market in coming future.  As per world cancer report by the end of year 2020 there will be 15 Million new cancer cases. The rising prevalence of cancer disease across the world like breast cancer, lung cancer, prostate cancer etc will drive the market of biopsy devices. These days, people are more health conscious and they are shifting towards minimal invasive technique over conventional technique to ensure complete safety. Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)" captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future. Biopsy Needle is one of the Significant Segment in Global Biopsy Device Market In this report, we have done comprehensive analysis of different types of Biopsy Device product. By biopsy device product, the market is categorized into 4 parts; Biopsy Needle, Guidance system segment, Biopsy Guns, Reagents and kits in which Biopsy needle is one of the most significant segment in global biopsy device market. Biopsy Needle segmented into two parts; Fine Aspiration Needles and Core Needle. Guidance system is further categorized into three parts; Ultrasound-guided, Stereotactic-guided and Clinically guided. Ultrasound-guided is the major segment among guidance system, where ultrasound is done to identify the abnormalities and then use needle to take sample of tissues from that particular places and this whole process takes 30 minutes. Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=biopsy-devices-market-global-forecast-p.php Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer's like Prostate, Breast and Lungs. Breast Biopsy is the Largest Application of Global Biopsy Device Market[b] In this report, we have fragmented the global biopsy device market on the basis of application into three parts; Breast Biopsy, Lung Biopsy and Prostate Biopsy. The prevalence of breast cancer and prostate cancer across the world is rising at the rapid pace and demand of minimally invasive surgeries among the people is also rising and hence it will further propel the market growth of global biopsy device. In this report, breast biopsy alone dominated the biopsy device market. [b]Asia-Pacific will be one of the Fastest Growing Markets for Biopsy Devices Globally In this report, we have done complete insight on regional analysis of global biopsy device market. We have categorized the market into four regional front; North America, Europe, Asia-Pacific and Rest of the world. Asia-Pacific will be one of the fastest growing markets for biopsy device.  Company Analysis The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market. Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=biopsy-devices-market-global-forecast-p.php All the 8 companies studied in the report have been studied from 4 points • Overview • Business Strategy • Merger & Acquisition • Financial Insight Biopsy Segments Covered in the Report: • Biopsy Needles • Guidance Systems • Biopsy Guns • Reagents and kits • Others  Regional Market Covered in the Report: • North America • Europe • Asia-Pacific • Rest of the World Key Companies Covered in the Report: • C. R. Bard, Inc. • Becton, Dickinson and Company • B. Braun Melsungen AG • Cardinal Health, Inc. • Olympus Corporation • Boston Scientific Corporation • Medtronic plc • Hologic, Inc. If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com About Us Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers andexecutives to make informed and correct decisions. Contact Us Renub Research Phone: +1-678-302-0700 Email: info@renub.com Website: www.renub.com Follow us on LinkedIn: www.linkedin.com/company/renub-research |
|
|
| |
 |
|
|
| Seite: « 1 » |
| [ Neuer Eintrag - letzter Post ] |
|
 |
|
|
vs. sf-c
33:15
8:40
vs. GD
halflife2